BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2108039)

  • 1. Altered collagen metabolism in osteogenesis imperfecta fibroblasts: a study on 33 patients with diverse forms.
    Brenner RE; Vetter U; Nerlich A; Wörsdorfer O; Teller WM; Müller PK
    Eur J Clin Invest; 1990 Feb; 20(1):8-14. PubMed ID: 2108039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteogenesis imperfecta: insufficient collagen synthesis in early childhood as evidenced by analysis of compact bone and fibroblast cultures.
    Brenner RE; Vetter U; Nerlich A; Wörsdorfer O; Teller WM; Müller PK
    Eur J Clin Invest; 1989 Apr; 19(2):159-66. PubMed ID: 2499474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormal type I collagen metabolism by cultured fibroblasts in lethal perinatal osteogenesis imperfecta.
    Bateman JF; Mascara T; Chan D; Cole WG
    Biochem J; 1984 Jan; 217(1):103-15. PubMed ID: 6421277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Collagen defects in lethal perinatal osteogenesis imperfecta.
    Bateman JF; Chan D; Mascara T; Rogers JG; Cole WG
    Biochem J; 1986 Dec; 240(3):699-708. PubMed ID: 3827862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three novel type I collagen mutations in osteogenesis imperfecta type IV probands are associated with discrepancies between electrophoretic migration of osteoblast and fibroblast collagen.
    Sarafova AP; Choi H; Forlino A; Gajko A; Cabral WA; Tosi L; Reing CM; Marini JC
    Hum Mutat; 1998; 11(5):395-403. PubMed ID: 9600458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Collagen metabolism in cultured osteoblasts from osteogenesis imperfecta patients.
    Mörike M; Brenner RE; Bushart GB; Teller WM; Vetter U
    Biochem J; 1992 Aug; 286 ( Pt 1)(Pt 1):73-7. PubMed ID: 1520286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteogenesis imperfecta type IV: evidence of abnormal triple helical structure of type I collagen.
    Wenstrup RJ; Hunter AG; Byers PH
    Hum Genet; 1986 Sep; 74(1):47-53. PubMed ID: 3759085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serine for glycine substitutions in type I collagen in two cases of type IV osteogenesis imperfecta (OI). Additional evidence for a regional model of OI pathophysiology.
    Marini JC; Lewis MB; Wang Q; Chen KJ; Orrison BM
    J Biol Chem; 1993 Feb; 268(4):2667-73. PubMed ID: 8094076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on type I collagen in skin fibroblasts cultured from twins with lethal osteogenesis imperfecta.
    Galicka A; Wołczyński S; Gindzieński A
    Acta Biochim Pol; 2003; 50(2):481-8. PubMed ID: 12833172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical analysis of callus tissue in osteogenesis imperfecta type IV. Evidence for transient overmodification in collagen types I and III.
    Brenner RE; Vetter U; Nerlich A; Wörsdorfer O; Teller WM; Müller PK
    J Clin Invest; 1989 Sep; 84(3):915-21. PubMed ID: 2760218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compositional analysis of collagen from patients with diverse forms of osteogenesis imperfecta.
    Kirsch E; Krieg T; Nerlich A; Remberger K; Meinecke P; Kunze D; Müller PK
    Calcif Tissue Int; 1987 Jul; 41(1):11-7. PubMed ID: 3113698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secreted collagen ratios in normal human and osteogenesis imperfecta skin fibroblasts.
    Fraser J; Lancaster GA; Scriver CR
    Connect Tissue Res; 1983; 11(1):57-67. PubMed ID: 6221880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dominantly inherited osteogenesis imperfecta in man: an examination of collagen biosynthesis.
    Lancaster G; Goldman H; Scriver CR; Gold RJ; Wong I
    Pediatr Res; 1975 Feb; 9(2):83-8. PubMed ID: 1118195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Osteogenesis imperfecta: contribution to pathobiochemistry].
    Pontz BF; Müller PK
    Padiatr Padol; 1984; 19(4):365-70. PubMed ID: 6504544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deposition and selective degradation of structurally-abnormal type I collagen in a collagen matrix produced by osteogenesis imperfecta fibroblasts in vitro.
    Bateman JF; Golub SB
    Matrix Biol; 1994 Apr; 14(3):251-62. PubMed ID: 7921542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type I procollagen in the severe non-lethal form of osteogenesis imperfecta. Defective pro-alpha 1(I) chains in a patient with abnormal proteoglycan metabolism and mineral deposits in the dermis.
    Tenni R; Cetta G; Dyne K; Rossi A; Quacci D; Lenzi L; Castellani AA
    Hum Genet; 1988 Jul; 79(3):245-50. PubMed ID: 3402997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative studies of osteoblast and fibroblast type I collagen in a patient with osteogenesis imperfecta type IV.
    Galicka A; Wolczynski S; Gindzienski A
    J Pathol; 2002 Feb; 196(2):235-7. PubMed ID: 11793376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteogenesis imperfecta: clinical, cephalometric, and biochemical investigations of OI types I, III, and IV.
    Jensen BL; Lund AM
    J Craniofac Genet Dev Biol; 1997; 17(3):121-32. PubMed ID: 9338855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotypic variability and abnormal type I collagen unstable at body temperature in a family with mild dominant osteogenesis imperfecta.
    Tenni R; Biglino P; Dyne K; Rossi A; Filocamo M; Pendola F; Brunelli P; Buttitta P; Borrone C; Cetta G
    J Inherit Metab Dis; 1991; 14(2):189-201. PubMed ID: 1886404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defects of type I procollagen metabolism correlated with decrease of prolidase activity in a case of lethal osteogenesis imperfecta.
    Galicka A; Wolczyñski S; Anchim T; Surazyñski A; Lesniewicz R; Palka J
    Eur J Biochem; 2001 Apr; 268(7):2172-8. PubMed ID: 11277941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.